Abivax S.A.
ABVX.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €426 | €423 | €118 | €441 |
| - Cash | €144 | €252 | €27 | €61 |
| + Debt | €97 | €55 | €39 | €53 |
| Enterprise Value | €379 | €226 | €130 | €434 |
| Revenue | €11 | €5 | €5 | €0 |
| % Growth | 133.5% | 0.8% | 12,286.5% | – |
| Gross Profit | €11 | €4 | €5 | -€0 |
| % Margin | 100% | 97.2% | 98.5% | -321.6% |
| EBITDA | -€168 | -€133 | -€53 | -€42 |
| % Margin | -1,553.8% | -2,882.6% | -1,163.3% | -114,040.5% |
| Net Income | -€176 | -€148 | -€61 | -€42 |
| % Margin | -1,633.1% | -3,197.1% | -1,325.3% | -114,735.1% |
| EPS Diluted | -2.8 | -3.43 | -3.18 | -2.75 |
| % Growth | 18.4% | -7.9% | -15.6% | – |
| Operating Cash Flow | -€154 | -€97 | -€66 | -€46 |
| Capital Expenditures | -€1 | -€0 | -€4 | -€2 |
| Free Cash Flow | -€155 | -€97 | -€70 | -€47 |